stocks logo

ASMB

Assembly Biosciences Inc
$
19.500
+0.95(5.121%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
19.500
Open
18.500
VWAP
--
Vol
19.44K
Mkt Cap
148.93M
Low
18.300
Amount
--
EV/EBITDA(TTM)
--
Total Shares
6.35M
EV
50.65M
EV/OCF(TTM)
--
P/S(TTM)
3.76
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
5.30M
-22.59%
--
--
5.30M
-37.91%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Assembly Biosciences, Inc. (ASMB) for FY2025, with the revenue forecasts being adjusted by -54.78% over the past three months. During the same period, the stock price has changed by 80.22%.
Revenue Estimates for FY2025
Revise Downward
down Image
-54.78%
In Past 3 Month
Stock Price
Go Up
up Image
+80.22%
In Past 3 Month
2 Analyst Rating
up Image
53.85% Upside
Wall Street analysts forecast ASMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASMB is 30.00 USD with a low forecast of 29.00 USD and a high forecast of 31.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
up Image
53.85% Upside
Current: 19.500
sliders
Low
29.00
Averages
30.00
High
31.00
Guggenheim
Vamil Divan
Strong Buy
Initiates
$31
2025-03-25
Reason
Guggenheim initiated coverage of Assembly Biosciences with a Buy rating and $31 price target.
HC Wainwright & Co.
Ed Arce
Hold
Reiterates
n/a
2025-03-24
Reason
HC Wainwright & Co.
Ed Arce
Hold
Reiterates
n/a
2024-12-27
Reason
HC Wainwright & Co.
Ed Arce
Hold
Reiterates
n/a
2024-09-24
Reason
Jefferies
Dennis Ding
Hold
to
Strong Buy
Upgrades
$2 → $35
2024-09-20
Reason

Valuation Metrics

The current forward P/E ratio for Assembly Biosciences Inc (ASMB.O) is -5.77, compared to its 5-year average forward P/E of -1.81. For a more detailed relative valuation and DCF analysis to assess Assembly Biosciences Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.81
Current PE
-5.77
Overvalued PE
-0.46
Undervalued PE
-3.15

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.01
Current EV/EBITDA
-1.20
Overvalued EV/EBITDA
0.20
Undervalued EV/EBITDA
-0.22

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
12.05
Current PS
5.91
Overvalued PS
36.88
Undervalued PS
-12.78

Financials

Annual
Quarterly
FY2025Q1
YoY :
+62.82%
9.42M
Total Revenue
FY2025Q1
YoY :
-7.34%
-9.94M
Operating Profit
FY2025Q1
YoY :
-2.85%
-8.82M
Net Income after Tax
FY2025Q1
YoY :
-29.52%
-1.17
EPS - Diluted
FY2025Q1
YoY :
+27.54%
-23.44M
Free Cash Flow
FY2025Q1
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q1
-174.80
FCF Margin - %
FY2025Q1
YoY :
-40.34%
-93.62
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
14.7K
USD
4
6-9
Months
0.0
USD
0
0-12
Months
5.2K
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
4
20.5M
USD
Months
0-12
1
145.8K
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 161.98% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
940.5K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

ASMB News & Events

Events Timeline

2025-07-27 (ET)
2025-07-27
10:34:27
Assembly Biosciences presents Phase 1a data for ABI-5366, ABI-1179
select
2025-06-30 (ET)
2025-06-30
08:07:22
Assembly announces first participant dosed in Phase 1b trial of ABI-1179
select
2025-06-25 (ET)
2025-06-25
08:14:18
Assembly Biosciences reports results from Phase 1b trial of ABI-4334
select
Sign Up For More Events

News

9.0
07-26Newsfilter
PinnedAssembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop
9.0
06-25Newsfilter
Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
9.0
04-09Newsfilter
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
Sign Up For More News

FAQ

arrow icon

What is Assembly Biosciences Inc (ASMB) stock price today?

The current price of ASMB is 19.5 USD — it has increased 5.12 % in the last trading day.

arrow icon

What is Assembly Biosciences Inc (ASMB)'s business?

arrow icon

What is the price predicton of ASMB Stock?

arrow icon

What is Assembly Biosciences Inc (ASMB)'s revenue for the last quarter?

arrow icon

What is Assembly Biosciences Inc (ASMB)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Assembly Biosciences Inc (ASMB)'s fundamentals?

arrow icon

How many employees does Assembly Biosciences Inc (ASMB). have?

arrow icon

What is Assembly Biosciences Inc (ASMB) market cap?